Clincosm LogoSign in Get a demo

Three-Factor Eating Questionnaire in Measuring Eating Behavior in Adolescent and Young Adult Survivors of CNS Tumors

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT01682824
Collaborator
National Cancer Institute (NCI) (NIH)
1
Enrollment
1
Location
104.3
Actual Duration (Months)
0
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This trial studies how the Three-Factor Eating Questionnaire works in measuring eating behavior in adolescent and young adult survivors of central nervous system (CNS) tumors. The Three-Factor Eating Questionnaire is comprised of three factors, including cognitive restraint, uncontrolled eating, and emotion eating. The Eating Questionnaire - Ecological Momentary Assessment method measures a patient's recent experiences and behavior, such as eating behavior, as they continue their daily living. Giving the Three-Factor Eating Questionnaire and the Eating Questionnaire - Ecological Momentary Assessment may help researchers measure eating behaviors more effectively in adolescent and young adult survivors of CNS tumors.

Condition or Disease Intervention/Treatment Phase
  • Other: Nutritional Assessment
  • Other: Questionnaire Administration
  • Other: Questionnaire Administration

Detailed Description

PRIMARY OBJECTIVES I. Evaluate whether the factor structure of the adapted Eating Questionnaire-Ecological Momentary Assessment (EQ-EMA), which has been modified for real time assessment, will be similar to the factor structures for cognitive restraint (CR) and uncontrollable eating (UE) factors assessed by the Three Factor Eating Questionnaire-R18v2 (TFEQ-R18v2) in a sample of adolescent and young adult (AYA) survivors of childhood central nervous system (CNS) tumors in the United States (US).

SECONDARY OBJECTIVES I. To validate the original TFEQ-R18v2 in a sample of AYA survivors of childhood CNS tumors in the US.

  1. To determine the association of the original TFEQ-R18v2 with self-reported body mass index (BMI).

  2. To determine the association of the original TFEQ-R18v2 with fruits and vegetables, fiber, and fat intake.

  3. To determine the association of EQ-EMA with self-reported BMI. V. To determine the association of EQ-EMA with fruits and vegetables, fiber, and fat intake.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients complete the TFEQ-R18v2 questionnaire, a dietary intake assessment, and the EQ-EMA questionnaire online.

GROUP II: Patients complete the EQ-EMA questionnaire, a dietary intake assessment and the TFEQ-R18v2 questionnaire.

Study Design

Study Type:
Observational
Actual Enrollment :
1 participants
Official Title:
MyChoice: An Application of the Three-Factor Eating Questionnaire (TFEQ-R18v2) Among Adolescent and Young Adult Survivors of CNS Tumors
Actual Study Start Date :
May 17, 2013
Actual Primary Completion Date :
Jan 24, 2022
Actual Study Completion Date :
Jan 24, 2022

Arms and Interventions

Arm Intervention/Treatment
Group I (questionnaire, nutritional assessment)

Patients complete the TFEQ-R18v2 questionnaire, a dietary intake assessment, and the EQ-EMA questionnaire online.

Other: Nutritional Assessment
Complete dietary intake assessment
Other Names:
  • Dietary Assessment
  • dietary counseling
  • nutritional counseling

    • Other: Questionnaire Administration
    Complete TFEQ-R18v2 questionnaire

    Other: Questionnaire Administration
    Complete EQ-EMA questionnaire
    Group II (questionnaire, nutritional assessment)

    Patients complete the EQ-EMA questionnaire, a dietary intake assessment and the TFEQ-R18v2 questionnaire.

    Other: Nutritional Assessment
    Complete dietary intake assessment
    Other Names:
  • Dietary Assessment
  • dietary counseling
  • nutritional counseling

    • Other: Questionnaire Administration
    Complete TFEQ-R18v2 questionnaire

    Other: Questionnaire Administration
    Complete EQ-EMA questionnaire

    Outcome Measures

    Primary Outcome Measures

    1. Similarity of factor structures between the Eating Questionnaire (EQ-EMA) and the Three-Factor Eating Questionnaire (TFEQ-R18v2) [Up to 6 years]

      Will use a structural equation modeling (SEM) methodology to examine the extent to which individual items comprising both the original TFEQ-R18v2 and the adapted EQ-EMA loaded on their respective factors (cognitive restraint [CR] and uncontrollable eating [UE]) and will examine the correlations between them.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 39 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Adolescent or young adult (AYA) who has survived a primary CNS tumor

    • Has been off therapy without relapse for at least 6 months

    • Able to speak, write, and read in English

    • Has access to the internet

    • Has telephone access

    • Currently lives in the United States

    Exclusion Criteria:

    • Is in foster care

    • Is experiencing severe cognitive impairments that do not allow them to engage in basic conversations (excluding individuals who may experience severe cognitive impairments because participants will need to provide assent [if < 18 years old] or consent [if >= 18 years old] and will need to have the ability to independently complete the TFEQ-R18v2, Multifactor screener, and EQ-EMA. Through the phone screening conducted by the M D Anderson Cancer Center [MDACC] graduate research assistant [GRA], a person is determined to not be severely cognitive impaired if the participant is able to respond to basic questions such as their age, whether or not they have internet access, and telephone.)

    • Is incarcerated at the time of enrollment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 M D Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Karen Basen-Engquist, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT01682824
    Other Study ID Numbers:
    • 2012-0628
    • NCI-2018-02536
    • 2012-0628
    First Posted:
    Sep 11, 2012
    Last Update Posted:
    Feb 3, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Central Nervous System Neoplasms

    Study Results

    No Results Posted as of Feb 3, 2022